Glen Eagle Advisors, LLC Celularity Inc Transaction History

Glen Eagle Advisors, LLC

  • $593 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 13, 2024
SELL
$0.22 - $0.56 $25 - $64
-115 Closed
0 $0
Q2 2022

Aug 13, 2024
BUY
$2.81 - $12.91 $323 - $1,484
115 New
115 $391,000

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email